T1	Participants 84 121	patients with decompensated cirrhosis
T2	Participants 367 451	Thirty-one patients with cirrhosis receiving norfloxacin (400 mg/day) were included.
T3	Participants 2193 2231	neutrophils in patients with cirrhosis
